BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 19351529)

  • 1. Laboratory assessment and perioperative management of patients on antiplatelet therapy: from the bench to the bedside.
    Lippi G; Favaloro EJ; Salvagno GL; Franchini M
    Clin Chim Acta; 2009 Jul; 405(1-2):8-16. PubMed ID: 19351529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative assessment of platelet function in patients under antiplatelet therapy.
    Hofer CK; Zollinger A; Ganter MT
    Expert Rev Med Devices; 2010 Sep; 7(5):625-37. PubMed ID: 20822386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring antiplatelet drug effects in the laboratory.
    Harrison P; Frelinger AL; Furman MI; Michelson AD
    Thromb Res; 2007; 120(3):323-36. PubMed ID: 17239428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet drugs: a review of their pharmacology and management in the perioperative period.
    Hall R; Mazer CD
    Anesth Analg; 2011 Feb; 112(2):292-318. PubMed ID: 21212258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of antiplatelet therapy for minimization of bleeding risk before cardiac surgery.
    Weant KA; Flynn JF; Akers WS
    Pharmacotherapy; 2006 Nov; 26(11):1616-25. PubMed ID: 17064207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet agents in the perioperative period.
    O'Riordan JM; Margey RJ; Blake G; O'Connell PR
    Arch Surg; 2009 Jan; 144(1):69-76; discussion 76. PubMed ID: 19153328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The genetics of antiplatelet drug resistance.
    Feher G; Feher A; Pusch G; Lupkovics G; Szapary L; Papp E
    Clin Genet; 2009 Jan; 75(1):1-18. PubMed ID: 19067731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An assessment of cardiopulmonary bypass-induced changes in platelet function using whole blood and classical light transmission aggregometry: the results of a pilot study.
    Velik-Salchner C; Maier S; Innerhofer P; Kolbitsch C; Streif W; Mittermayr M; Praxmarer M; Fries D
    Anesth Analg; 2009 Jun; 108(6):1747-54. PubMed ID: 19448196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current options in platelet function testing.
    Michelson AD; Frelinger AL; Furman MI
    Am J Cardiol; 2006 Nov; 98(10A):4N-10N. PubMed ID: 17097417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet function testing and implications for clinical practice.
    Collet JP; Montalescot G
    J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):157-69. PubMed ID: 19721130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet agents in the perioperative period: expert recommendations of the French Society of Anesthesiology and Intensive Care (SFAR) 2001--summary statement.
    Samama CM; Bastien O; Forestier F; Denninger MH; Isetta C; Juliard JM; Lasne D; Leys D; Mismetti P;
    Can J Anaesth; 2002; 49(6):S26-35. PubMed ID: 12557412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet drugs : is there a surgical risk?
    Daniel NG; Goulet J; Bergeron M; Paquin R; Landry PE
    J Can Dent Assoc; 2002 Dec; 68(11):683-7. PubMed ID: 12513936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring oral antiplatelet therapy: is it justified?
    Ang L; Mahmud E
    Ther Adv Cardiovasc Dis; 2008 Dec; 2(6):485-96. PubMed ID: 19124443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet 'resistance' and 'non-responders': what do these terms really mean?
    Serebruany VL; Eisert C; Atar D; Ferguson JJ
    Fundam Clin Pharmacol; 2009 Feb; 23(1):11-8. PubMed ID: 19267767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Perioperative management of new antiplatelet drugs].
    Schnyder-Joris C; Bonhomme F; Bonvini R; Fontana P
    Rev Med Suisse; 2013 Feb; 9(372):326-30. PubMed ID: 23469401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel P2Y12 adenosine diphosphate receptor antagonists for inhibition of platelet aggregation (I): in vitro effects on platelets.
    Bryant J; Post JM; Alexander S; Wang YX; Kent L; Schirm S; Tseng JL; Subramanyam B; Buckman B; Islam I; Yuan S; Sullivan ME; Snider M; Morser J
    Thromb Res; 2008; 122(4):523-32. PubMed ID: 18495218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of platelet function: does it offer a chance of better cancer progression control?
    Sierko E; Wojtukiewicz MZ
    Semin Thromb Hemost; 2007 Oct; 33(7):712-21. PubMed ID: 18000800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variable platelet responsiveness to aspirin and clopidogrel: role of platelet function and genetic polymorphism testing.
    Azam SM; Jozic J
    Transl Res; 2009 Dec; 154(6):309-13. PubMed ID: 19931197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of surgical patients receiving anticoagulation and antiplatelet agents.
    Thachil J; Gatt A; Martlew V
    Br J Surg; 2008 Dec; 95(12):1437-48. PubMed ID: 18991253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Platelet function analysis with point-of-care methods].
    Görlinger K; Jambor C; Dirkmann D; Dusse F; Hanke A; Adamzik M; Hartmann M; Philipp S; Weber AA; Rahe-Meyer N
    Herz; 2008 Jun; 33(4):297-305. PubMed ID: 18581079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.